ArticleTranslational cancer research2022

Allogeneic CAR-T bridging to allo-HSCT as a treatment strategy for refractory adult Burkitt's lymphoma: a case report.

Ling Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.